Association Between E-Cigarette Use and Chronic Obstructive Pulmonary Disease by Smoking Status: Behavioral Risk Factor Surveillance System 2016 and 2017
- PMID: 31902685
- PMCID: PMC9843649
- DOI: 10.1016/j.amepre.2019.10.014
Association Between E-Cigarette Use and Chronic Obstructive Pulmonary Disease by Smoking Status: Behavioral Risk Factor Surveillance System 2016 and 2017
Abstract
Introduction: The association between e-cigarette use and chronic bronchitis, emphysema, and chronic obstructive pulmonary disease has not been studied thoroughly, particularly in populations defined by concomitant combustible smoking status.
Methods: Using pooled 2016 and 2017 data from the Behavioral Risk Factor Surveillance System, investigators studied 705,159 participants with complete self-reported information on e-cigarette use, combustible cigarette use, key covariates, and chronic bronchitis, emphysema, or chronic obstructive pulmonary disease. Current e-cigarette use was the main exposure, with current use further classified as daily or occasional use. The main outcome was defined as reported ever having a diagnosis of chronic bronchitis, emphysema, or chronic obstructive pulmonary disease. For all the analyses, multivariable adjusted logistic regression was used, with the study population stratified by combustible cigarette use status (never, former, or current). All the analyses were conducted in 2019.
Results: Of 705,159 participants, 25,175 (3.6%) were current e-cigarette users, 64,792 (9.2%) current combustible cigarette smokers, 207,905 (29.5%) former combustible cigarette smokers, 432,462 (61.3%) never combustible cigarette smokers, and 14,036 (2.0%) dual users of e-cigarettes and combustible cigarettes. A total of 53,702 (7.6%) participants self-reported chronic bronchitis, emphysema, or chronic obstructive pulmonary disease. Among never combustible cigarette smokers, current e-cigarette use was associated with 75% higher odds of chronic bronchitis, emphysema, or chronic obstructive pulmonary disease compared with never e-cigarette users (OR=1.75, 95% CI=1.25, 2.45), with daily users of e-cigarettes having the highest odds (OR=2.64, 95% CI=1.43, 4.89). Similar associations between e-cigarette use and chronic bronchitis, emphysema, or chronic obstructive pulmonary disease were noted among both former and current combustible cigarette smokers.
Conclusions: The results suggest possible e-cigarette-related pulmonary toxicity across all the categories of combustible cigarette smoking status, including those who had never smoked combustible cigarettes.
Copyright © 2019 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.
Figures

Similar articles
-
The association between e-cigarette use and asthma among never combustible cigarette smokers: behavioral risk factor surveillance system (BRFSS) 2016 & 2017.BMC Pulm Med. 2019 Oct 16;19(1):180. doi: 10.1186/s12890-019-0950-3. BMC Pulm Med. 2019. PMID: 31619218 Free PMC article.
-
Use of Electronic Cigarettes and Self-Reported Chronic Obstructive Pulmonary Disease Diagnosis in Adults.Nicotine Tob Res. 2020 Jun 12;22(7):1155-1161. doi: 10.1093/ntr/ntz234. Nicotine Tob Res. 2020. PMID: 31830263 Free PMC article.
-
Association Between E-Cigarette Use and Cardiovascular Disease Among Never and Current Combustible-Cigarette Smokers.Am J Med. 2019 Aug;132(8):949-954.e2. doi: 10.1016/j.amjmed.2019.02.016. Epub 2019 Mar 8. Am J Med. 2019. PMID: 30853474
-
How effective are electronic cigarettes for reducing respiratory and cardiovascular risk in smokers? A systematic review.Harm Reduct J. 2020 Nov 23;17(1):91. doi: 10.1186/s12954-020-00440-w. Harm Reduct J. 2020. PMID: 33228671 Free PMC article.
-
E-cigarette use and combustible tobacco cigarette smoking uptake among non-smokers, including relapse in former smokers: umbrella review, systematic review and meta-analysis.BMJ Open. 2021 Mar 30;11(3):e045603. doi: 10.1136/bmjopen-2020-045603. BMJ Open. 2021. PMID: 33785493 Free PMC article.
Cited by
-
E-Cigarette Use: Device Market, Study Design, and Emerging Evidence of Biological Consequences.Int J Mol Sci. 2021 Nov 18;22(22):12452. doi: 10.3390/ijms222212452. Int J Mol Sci. 2021. PMID: 34830344 Free PMC article. Review.
-
Cannabis vaping among adults in the United States: Prevalence, trends, and association with high-risk behaviors and adverse respiratory conditions.Prev Med. 2021 Dec;153:106800. doi: 10.1016/j.ypmed.2021.106800. Epub 2021 Sep 11. Prev Med. 2021. PMID: 34520787 Free PMC article.
-
Association of tobacco product use with chronic obstructive pulmonary disease (COPD) prevalence and incidence in Waves 1 through 5 (2013-2019) of the Population Assessment of Tobacco and Health (PATH) Study.Respir Res. 2022 Oct 1;23(1):273. doi: 10.1186/s12931-022-02197-1. Respir Res. 2022. PMID: 36183112 Free PMC article.
-
Association of flavored electronic nicotine delivery system (ENDS) use with self-reported chronic obstructive pulmonary disease (COPD): Results from the Population Assessment of Tobacco and Health (PATH) study, Wave 4.Tob Induc Dis. 2020 Oct 1;18:82. doi: 10.18332/tid/127238. eCollection 2020. Tob Induc Dis. 2020. PMID: 33082739 Free PMC article.
-
Nose-Only Exposure to Cherry- and Tobacco-Flavored E-Cigarettes Induced Lung Inflammation in Mice in a Sex-Dependent Manner.Toxics. 2022 Aug 13;10(8):471. doi: 10.3390/toxics10080471. Toxics. 2022. PMID: 36006150 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical